Assessment of hepatic sensitivity to glucagon in NIDDM: Use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis

Diabetes

Volumn 46, Issue 12, 1997, Pages 2007-2016

  Nielsen, Michael F ^a   Wise, Steven ^a   Dinneen, Sean F ^a   Schwenk, W Frederick ^a   Basu, Ananda ^a   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0030815255     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.12.2007     Document Type: Article

References (60)

1. Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957-969, 1981
2. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (Type II) diabetes mellitus. J Clin Invest 76:149-155, 1985
3. Firth RG, Bell PM, Rizza RA Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 314:1280-1286, 1986
4. Campbell PJ, Mandarino LJ, Gerich JE: Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37:15-21, 1988
5. Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R: The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 95:755-762, 1995
6. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 77:1525-1532, 1986
7. Ferrannini E, Simonson DC, Katz LD, Reichard G Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA: The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37:79-85, 1988
8. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
9. Cherrington AD, Chiasson JL, Liljenquist JE, Jennings AS, Keller U, Lacy WW: The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest 58:1407-1418, 1976
10. Fradkin J, Shamoon H, Felig P, Sherwin RS: Evidence for an important role of changes in, rather than absolute concentrations of, glucagon in the regulation of glucose production in humans. J Clin Endocrinol Metab 50:698-703, 1980
11. Parrilla R, Goodman MN, Toews CJ: Effect of glucagon: insulin ratios on hepatic metabolism. Diabetes 23:725-731, 1974
12. Sherwin RS, Fisher M, Hendler R, Felig P: Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med 294:455-461, 1976
13. Raskin P, Unger RH: Hyperglucagonemia and its suppression: importance in the metabolic control of diabetes. N Engl J Med 299:433-436, 1978
14. Reaven GM, Chen Y-DI, Swislocki ALM, Jaspan JP: Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:106-110, 1987
15. Butler RC, Rizza RA: Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 40:73-81, 1991
16. Amer P, Einarsson K, Ewerth S, Livingston JN: Altered action of glucagon on human liver in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:323-326, 1987
17. Hansen LH, Abrahamsen N, Hager J, Jelinek L, Kindsvogel W, Froguel P, Nishimura E: The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes 45:725-730, 1996
18. Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W, Velho G, Carcassi C, Contu L, Julier C: A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet 9:299-304, 1995
19. Jackson RA, Perry G, Rogers J, Advani U, Pilkington TRE: Relationship between the basal glucose concentration, glucose tolerance and forearm glucose uptake in maturity-onset diabetes. Diabetes 22:751-761, 1973
20. Cherrington AD, Williams PE, Shulman GI, Lacy WW: Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes 30:180-187, 1981
21. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI: Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44:185-189, 1995
22. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI: Increased rate of gluconeogenesis in Type II diabetes mellitus. J Clin Invest 90:1323-1327, 1992
23. Katz J, McGarry JD: The glucose paradox: Is glucose a substrate for liver metabolism? J Clin Invest 74:1901-1909, 1984
24. Bismut H, Plas C: Pathways of glycogen synthesis from glucose during the glycogenic response to insulin in cultured foetal hepatocytes. Biochem J 263:889-895, 1989
25. Newgard CB, Moore SV, Foster DW, McGarry JD: Efficient hepatic glycogen synthesis in refeeding rats requires continued carbon flow through the gluconeogenic pathway. J Biol Chem 259:6958-6963, 1984
26. Shulman GI, Cline G, Shumann WC, Chandramouli V, Kumaran K, Landau BR: Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. Am J Physiol 259:E335-E341, 1990
27. Youn JH, Bergman RN: Enhancement of hepatic glycogen by gluconeogenic precursors: substrate flux or metabolic control? Am J Physiol 258:E899-E906, 1990
28. Zhang Z, Radziuk J: Coordinated regulation of hepatic glycogen formation in perfused rat liver by glucose and lactate. Am J Physiol 266:E583-E591, 1994
29. Hellerstein MK, Kaempfer S, Reid JS, Wu K, Shackleton CHL: Rate of glucose entry into hepatic uridine diphosphoglucose by the direct pathway in fasted and fed states in normal humans. Metabolism 44:172-182, 1995
30. Hwang J, Perseghin G, Rothman DL, Cline GW, Magnusson I, Petersen KF, Shulman GI: Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. J Clin Invest 95:783-787, 1995
31. Giaccari A, Rossetti L: Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J Clin Invest 89:36-45, 1992
32. Landau BR, Leonards JR: Significance of changes in blood glucose specific activity following insulin administration. Am J Physiol 198:793-796, 1960
33. Landau B, Leonards JR, Barry FM: A quantitative study of glucagon-induced hepatic glycogenolysis. Am J Physiol 199:231-234, 1960
34. Wajngot A, Chandramouli V, Schumann WC, Kumaran K, Efendic S, Landau BR: Testing of the assumptions made in estimating the extent of futile cycling. Am J Physiol 256:E668-E675, 1989
35. White NH, Skor D, Santiago JV: Practical closed-loop insulin delivery: a system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med 97:210-213, 1982
36. Rizza RA, Gerich JE: Persistent effect of sustained hyperglucagonemia on glucose production in man. J Clin Endocrinol Metab 48:352-355, 1979
37. Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA: Abnormal meal carbohydrate disposition in insulin-dependent diabetes. J Clin Invest 74:985-991, 1984
38. Rother KI, Schwenk WF: Hepatic glycogen accurately reflected by acetaminophen glucuronide in dogs refed after fasting. Am J Physiol 269:E766-E773, 1995
39. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments: basis for adaptive time course smoothing. Am J Physiol 264:E902-E911, 1993
40. Steele R, Wall JS, De Bodo RC, Altszuler N, Kiang SP, Bjerknes C: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
41. Butler PC, Caumo A, Zerman A, O'Brien PC, Cobelli C, Rizza RA: Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol 264:E548-E569, 1993
42. Steiner G, Morita S, Vranic M: Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes 29:899-905, 1980
43. Vranic M, Morita S, Steiner G: Insulin resistance in obesity as analyzed by the response of glucose kinetics to glucagon infusion. Diabetes 29:169-176, 1980
44. Baron AD, Schaeffer L, Shragg P, Kolterman OG: Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 36:274-283, 1987
45. Cersosimo E, Judd RL, Miles JM: Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest 93:2584-2589, 1994
46. Stumboll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J: Uptake and release of glucose by the human kidney. J Clin Invest 96:2528-2533, 1995
47. Stumvoll M, Meyer C, Chintalapudi U,Guitarrez O, Kreider M, Perriello G, Welle S, Gerich J: Human renal glucose and glutamine metabolism: effects of glucagon (Abstract). Diabetes 45:34A, 1996
48. Cherrington AD, Vranic M: Role of glucagon and insulin in control of glucose turnover. Metabolism 20:625-628, 1971
49. Bomboy JD Jr, Lewis SB, Lacy WW, Sinclair-Smith BC, Liljenquist JE: Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man. Diabetes 26:177-184, 1977
50. Wajngot A, Chandramouli V, Schumann WC, Efendic S, Landau BR: Quantitation of glycogen/glucose-1-P cycling in liver. Metabolism 40:877-881, 1991
51. Landau BR, Wilson TH: The role of phosphorylation in glucose absorption from the intestine of the Golden hamster. J Biol Chem 234:749-753, 1959
52. David M, Petit WA, Laughlin MR, Shulman RG, King JE, Barrett EJ: Simultaneous synthesis and degradation of rat liver glycogen. J Clin Invest 86:612-617, 1990
53. Steiner KE, Williams PE, Lacy WW, Cherrington AD: Effects of insulin on glucagon-stimulated glucose production in the conscious dog. Metabolism 39:1325-1133, 1990
54. Bishop JS, Steele R, Altszuler N, Dunn A, Bjerknes C, De Bodo RC: Effects of insulin on liver glycogen synthesis and breakdown in the dog. Am J Physiol 208:307-316, 1965
55. Gonzalez-Manchon C, Martin-Requero A, Ayuso MS, Parrilla R: Role of endogenous fatty acids in the control of hepatic gluconeogenesis. Arch Biochem Biophys 292:95-101, 1992
56. Clore JN, Glickman PS, Nestler JE, Blackard WG: In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol 261:E425-E429, 1991
57. Jenssen T, Nurjhan N, Consoli A, Gerich JE: Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. J Clin Invest 86:489-497, 1990
58. Caro JF, Triester S, Patel VK, Tapscott EB, Leggett Frazier N, Dohm GL: Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27: 19-22, 1995
59. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Mykkanen L, Deeb SS: Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance. Diabetes Care 18:398-400, 1995
60. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte D Jr: A variation at position - 30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes 45:422-428, 1996